Lately, the bears have had a louder voice on the social media giant, but the bulls may come rushing in. Read More...
Motley Fool
Is Bionano Genomics a Buy?
High-flying growth stocks like Bionano Genomics (NASDAQ: BNGO) tend to be controversial among different crowds of investors. In my view, the biggest point in favor of investing in Bionano Genomics is that its business model will lead to a huge amount of recurring income over time, thereby leading to a virtuous cycle in which it can afford to funnel more and more money into developing new products. Bionano makes a genome-mapping instrument called the Saphyr, which is specialized in detecting major structural variations in chromosomes, such as large insertions or deletions and translocations.
Add Comment